U.S. patent application number 10/346890 was filed with the patent office on 2003-06-12 for ultrasound method for revascularization and drug delivery.
This patent application is currently assigned to SciMed Life Systems, Inc.. Invention is credited to DeVore, Lauri J..
Application Number | 20030109821 10/346890 |
Document ID | / |
Family ID | 25199295 |
Filed Date | 2003-06-12 |
United States Patent
Application |
20030109821 |
Kind Code |
A1 |
DeVore, Lauri J. |
June 12, 2003 |
Ultrasound method for revascularization and drug delivery
Abstract
A method and device for improving blood circulation to an area
of interest within a patient' heart is described. The method
comprises inserting a guidable elongated flexible ultrasound device
into a patient's vasculature, applying ultrasonic energy to an area
in need of improved circulation, and injecting materials such as
angiogenic materials or contrasting agents into the area of
interest. The device, suitable for performing the method, comprises
an elongated tubular body, a distal head of the elongated tubular
body for introducing ultrasonic energy to an area of interest, and
a needle to deliver materials to an area of interest.
Inventors: |
DeVore, Lauri J.; (Seattle,
WA) |
Correspondence
Address: |
CHRISTENSEN, O'CONNOR, JOHNSON, KINDNESS, PLLC
1420 FIFTH AVENUE
SUITE 2800
SEATTLE
WA
98101-2347
US
|
Assignee: |
SciMed Life Systems, Inc.
|
Family ID: |
25199295 |
Appl. No.: |
10/346890 |
Filed: |
January 15, 2003 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10346890 |
Jan 15, 2003 |
|
|
|
09808624 |
Mar 14, 2001 |
|
|
|
6508783 |
|
|
|
|
Current U.S.
Class: |
604/22 |
Current CPC
Class: |
A61B 2017/00247
20130101; A61M 37/0092 20130101; A61M 25/0084 20130101; A61M
2210/125 20130101; A61N 7/00 20130101; A61M 2205/058 20130101; A61M
2025/0089 20130101; A61B 2018/00392 20130101 |
Class at
Publication: |
604/22 |
International
Class: |
A61B 017/20 |
Claims
What is claimed is:
1. A method for improving blood circulation to an area of interest
in a heart muscle of a patient, said method comprising the steps
of: inserting a guidable elongated flexible ultrasound device into
said patient's vasculature, said guidable elongated flexible
ultrasound device having an elongate lumen, a distal end, a
proximal end, a distal head mounted on said distal end, and a
needle mounted to said elongated tubular body in fluid
communication with said lumen; guiding said distal head to said
area of interest in said heart muscle; applying ultrasonic energy
via said distal head to said area of interest; and injecting a
material into said area of interest with said needle.
2. The method of claim 1, wherein said material is an angiogenic
material.
3. The method of claim 1, wherein said material is a contrasting
agent.
4. The method of claim 1, wherein the step of applying said
ultrasonic energy further comprises the step of massaging said area
of interest without removing any portion of said heart muscle at
said area of interest.
5. The method of claim 1, wherein said needle is attached adjacent
to said distal head.
6. The method of claim 1, wherein said needle extends from said
distal head.
7. The method of claim 1, wherein the step of inserting said
guidable elongated flexible ultrasound device further comprises the
step of inserting a guidewire into said patient's vasculature and
passing said guidable elongated flexible ultrasound device over
said guidewire.
8. The method of claim 1, wherein said guidable elongated flexible
ultrasound device includes an endoscopic visualization device for
visualizing said area of interest.
9. A method for improving blood circulation to an external area of
interest in a heart muscle of a patient, said method comprising the
steps of: providing a guidable elongated flexible ultrasound device
into said patient's chest cavity, said guidable elongated flexible
ultrasound device having an elongate lumen, a distal end, a
proximal end, a distal head mounted on said distal end, and a
needle with a lumen mounted to said elongated tubular body in fluid
communication with said lumen; guiding said distal head within said
patient's chest cavity to contact said exterior area of interest of
said heart muscle; applying ultrasonic energy via said distal head
to said external area of interest; and injecting a material into
said area of interest with said needle.
10. The method of claim 9, wherein said material is an angiogenic
material.
11. The method of claim 9, wherein said material is a contrasting
agent.
12. The method of claim 9, wherein the step of applying said
ultrasonic energy further comprises the step of massaging said
external area of interest without removing any portion of said
heart muscle at said external area of interest.
13. The method of claim 9, wherein said needle is attached adjacent
to said distal head.
14. The method of claim 9, wherein said needle extends from said
distal head.
15. A guidable elongated flexible ultrasound device for increasing
the blood circulation to an area of interest in a heart muscle of a
patient comprising: an elongated tubular body having a lumen, a
longitudinal axis, a distal end and a proximal end; a distal head
mounted on said distal end for introducing ultrasonic waves to said
area of interest; and a needle for injecting a material into said
area of interest, said needle mounted to said elongated tubular
body substantially parallel to said longitudinal axis of said
tubular body.
16. The guidable elongated flexible ultrasound device as recited in
claim 15, wherein said material is an angiogenic material.
17. The guidable elongated flexible ultrasound device as recited in
claim 16, wherein said material is a contrasting agent.
18. The guidable elongated flexible ultrasound device of claim 15,
wherein said needle is attached adjacent to said elongated tubular
body.
19. The guidable elongated flexible ultrasound device of claim 15,
wherein said needle is attached to said elongated tubular body
within said lumen of said elongated tubular body.
20. The guidable elongated flexible ultrasound device of claim 15,
further comprising a guidewire for inserting into said patient's
vasculature and passing said guidable elongated flexible ultrasound
device over said guidewire.
Description
BACKGROUND OF THE INVENTION
[0001] 1. Technical Field of the Invention
[0002] The present invention relates generally to medical devices
for generating an angiogenic response in an interior wall of the
heart using a percutaneous myocardial revascularization (PMR)
procedure. More specifically, the present invention relates to an
intravascular ultrasound PMR device having a needle for supplying
the heart with an angiogenic material or contrasting agent.
[0003] 2. Description of the Prior Art
[0004] There is a great deal of interest in improving the methods
for treating cardiovascular disease. Traditionally, cardiovascular
disease has been treated using procedures such as cardiovascular
bypass surgery, coronary angioplasty, laser angioplasty and
atherectomy. These techniques generally are aimed at bypassing or
opening lesions in coronary vessels so as to restore and increase
blood flow to the heart. In some patients, the number of lesions is
so great, or the location so remote in the patient's vasculature
that restoring blood flow to the heart muscle is difficult.
Therefore, it is often the case that cardiovascular disease
requires alternative treatment such as percutaneous myocardial
revascularization (PMR).
[0005] PMR was developed as a less invasive alternative to bypass
surgery. PMR was inspired in part by observations that reptilian
hearts are supplied primarily by blood perfusing directly from
within heart chambers. In contrast, coronary vessels receiving
blood from the aorta supply the human heart. PMR is performed by
boring channels directly into the myocardium. This can be
accomplished by a number of means including the insertion of a
flexible catheter through the vasculature into the heart and boring
holes into the myocardium. Positive results have been demonstrated
in some human patients receiving these types of PMR treatments.
These results are believed to be caused in part by increased blood
flowing from within a heart chamber through channels formed by PMR
to the myocardial tissue. Increased blood flow to the myocardium is
also believed to be caused in part by the healing response to wound
formation. Specifically, the formation of new blood vessels is
believed to occur in response to the newly created wound.
[0006] Suitable PMR holes have been burned by laser, cut by
mechanical means, removed by ultrasound devices, and burned by
radio frequency current devices in a technique called radio
frequency percutaneous myocardial revascularization (RF-PMR). In
addition, catheter based needle injections of an angiogenic
material directly into the myocardium has been developed in
conjunction with RF-PMR. U.S. Pat. No. 6,063,082 to DeVore et al.
entitled "Percutaneous Myocardial Revascularization Basket Delivery
System and Radiofrequency Therapeutic Device" discloses a method in
which an angiogenic material can be delivered into a hole recently
burned by RF current delivered through the needle. Unfortunately,
in this method the angiogenic material may seep out of the hole
created by the RF-PRM electrode, thus reducing the effectiveness of
the angiogenic material.
[0007] U.S. Pat. No. 5,827,203 to Nita entitled "Ultrasound system
and Method For Myocardial Revascularization" discloses a method
that uses' ultrasonic energy to accomplish PMR. Ultrasound PMR
offers advantages over other PMR techniques in that the method is
less invasive and that in some embodiments no tissue needs to be
removed. The application of ultrasonic energy to an area of
interest produces a thrombus required for angiogenesis without
rupturing endocardial tissue. However, this method currently lacks
the ability to deliver additional interventions, such as the
delivery of angiogenic materials, to an area of interest. Thus,
physicians are limited in their ability to use this method and are
required to form channels in the heart wall if massaging an area of
interest does not produce the desired effect. Further, if massaging
an area of interest is insufficient to induce myocardial
revascularization, the ultrasound device is used to bore channels.
By including a means for delivering angiogenic materials, the need
for using the ultrasound device to bore channels should be
reduced.
[0008] New research conducted by the applicant suggests that the
thrombus, caused by the application of ultrasonic energy, in and
around the injury site contains the natural growth factors which
cause the angiogenic response. Therefore, destruction of heart
tissue, as with RF-PMR, may not be necessary to invoke an
angiogenic response. Consequently, there is a need for a method of
PMR that creates a natural angiogenic response without creating
unnecessary injury to an area of interest. Additionally, it would
be beneficial for this method to be able to deliver additional
angiogenic material to an area of interest in order to minimize
both the destruction of cardiac tissue and seepage.
SUMMARY OF THE INVENTION
[0009] A preferred embodiment of the present invention provides a
minimally invasive device for the treatment of cardiovascular
disease via ultrasound myocardial revascularization that
additionally provides means for direct delivery of angiogenic
materials. Combining ultrasound myocardial revascularization with
an additional lumen for the delivery of angiogenic materials offers
advantages over the prior art. Since it is believed that the
thrombus contains the natural growth factors capable of
facilitating an angiogenic response, this invention can accentuate
the body's own natural healing ability without destroying tissue.
Further, since no myocardial tissue is destroyed, seepage of
angiogenic materials is minimized. Finally, a contrasting agent can
be delivered through the needle to enable the physician to image an
area of interest.
[0010] In one embodiment of this invention, a needle is attached to
the ultrasound PMR device adjacent to the catheter along the
catheter's longitudinal axis. Angiogenic materials or a contrasting
agent can be delivered to an area of interest through the
needle.
[0011] In another embodiment, the needle passes through the lumen
of the ultrasound catheter. Angiogenic materials or a contrasting
agent can be delivered to an area of interest through the
needle.
BRIEF DESCRIPTION OF THE DRAWINGS
[0012] FIG. 1 is a perspective view of an ultrasound PMR catheter
system wherein a needle is attached adjacent to the ultrasound
catheter along the catheter's longitudinal axis;
[0013] FIG. 2 is a schematic section of a human heart showing
percutaneous revascularization of the myocardium according to the
present invention; and
[0014] FIG. 3 is a perspective view of an ultrasound PMR catheter
system wherein a needle is attached within the lumen of the
ultrasound catheter.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0015] Referring now to the drawings wherein like reference
numerals refer to like elements throughout the several views, FIG.
1 illustrates a guidable elongated flexible ultrasound device for
increasing blood circulation to an area of interest within the
heart of a patient. The guidable elongated flexible ultrasound
device includes an elongated tubular body 10 with a proximal end
closest to the outside of the body and a distal end closest to an
area of interest within a patient's heart. In the preferred
embodiment, the elongated tubular body 10 is constructed of
flexible material to easily pass through turns of the vasculature.
The elongated tubular body 10 has at least one lumen 12, extending
along the longitudinal axis 14 thereof.
[0016] The distal head 16 of the elongated tubular body includes an
ultrasonic catheter device that can be connected to a signal
generator by an ultrasound transmission lead 18. As such, when a
signal generator sends ultrasonic energy through the ultrasound
transmission lead 18, ultrasonic energy will pass through the
distal head 16 to an area of interest and can be used to massage
the myocardium 30. More specifically, the ultrasound transmission
lead 18 serves to transmit ultrasonic energy from the proximal end
of the elongated flexible ultrasound device to the distal head 16
of the elongated tubular body 10, and then to an area of
interest.
[0017] The guidable elongated flexible ultrasound device can reach
an area of interest by first inserting a guidewire 19 into the
patient's vasculature and passing the elongated tubular body 10
over said guidewire 19. In the preferred embodiment, the guidewire
19 can pass through a lumen within the elongated tubular body
ranging from the elongated tubular body's far proximal end through
the distal head and then through a lumen 21 within said distal
head. One skilled in the art can insert the guidewire 19 through a
patient's vasculature and into the patient's heart to an area of
interest. Then, the elongated tubular body 10 can be passed over
said guidewire 19 through a lumen therein to an area of
interest.
[0018] Mounted adjacent to the elongated tubular body 10 is a
needle 20 with a lumen 22 for injecting material 24 near a thrombus
26. In the preferred embodiment, the needle is constructed of
stainless steel. The lumen 22 of the needle 20 is of sufficient
diameter to allow passage of angiogenic materials or contrasting
agents. Angiogenic materials comprise a plethora of substances
including but not limited to pharmaceutically active compounds,
nucleic acids (including polynucleotide sequences), peptides
(including polypeptides and proteins), oligonucleotides, ribozymes,
anti-sense genes, DNA compacting agents, and gene/vector systems
(i.e., anything that allows for the uptake and expression of
nucleic acids).
[0019] For example, nucleic acids that may comprise angiogenic
materials include antisense DNA and RNA, DNA coding for an
anti-sense RNA, or DNA coding for tRNA, or rRNA to replace
defective or deficient endogenous molecules. The angiogenic
polynucleotides may also code for therapeutic peptides,
polypeptides and proteins. A polypeptide is understood to be any
translational product of a polynucleotide regardless of size, and
whether glycosylated or not.
[0020] Therapeutic polypeptides that may act as angiogenic factors
including acidic and basic fibroblast growth factors, vascular
endothelial growth factor, epidermal growth factor, transforming
growth factor .alpha. and .beta., platelet-derived endothelial
growth factor, platelet-derived growth factor, tumor necrosis
factor .alpha., hepatocyte growth factor and insulin like growth
factor; growth factors; cell cycle inhibitors including CDK
inhibitors; thymidine kinase ("TK") and other agents useful for
interfering with cell proliferation, including agents for treating
malignancies; and combinations thereof.
[0021] In another embodiment of the present invention, angiogenic
materials may include a viral vector having linked thereto an
exogenous nucleic acid sequence. "Exogenous nucleic acid sequence"
is used herein to mean a sequence of nucleic acids that is
exogenous to the virus from which the vector is derived. The
concentration of the viral vector, preferably an adenoviral vector,
is at least about 10.sup.10 plaque forming units ("p.f.u."), or
limited by the concentration that results in an undesirable immune
response from a patient.
[0022] Contrasting agents comprise substances including but not
limited to those that enable a physician performing the method or
using the device to accumulate information useful for completing or
evaluating the procedure. Example of contrasting agents include but
are not limited to saline (0.9% NaCl) that can flood the tip of the
guidable elongated flexible ultrasound device so as to enable
visualization of an area of interest or the device's location
within the vasculature, radioactive or radiolabeled magnetic
compounds useful for tracing during or after performing the method,
and anti-thrombin or blood thinning compounds (including heparin,
heparin derivatives, urokinase, dextrophenylalanine proline
arginine chloromethylketone, rapamycin, probucol, and
verapamil).
[0023] Applying ultrasonic energy to the endocardial layer 28 of
the myocardium 30 generates the thrombus 26. One skilled in the art
can massage the myocardium 30 with ultrasonic energy emitted
through the distal head 16 of the elongated tubular body 10. When
ultrasonic energy is applied to the myocardium 30, it causes
relaxation of the cardiac muscle and vasodilation (relaxation of
the vasculature that may result in increased blood flow to the area
wherein ultrasonic energy is used upon). In an embodiment of the
invention, when the myocardium 30 is massaged, preferably no heart
tissue or an insignificant amount is removed from the endocardium
28. A sufficient amount of massaging can lead to the formation of
at least one thrombus 26 wherein blot clotting and wound healing
can take place and lead to myocardial revascularization. Once a
thrombus is formed, the needle 20 can be used to deliver angiogenic
materials or contrasting agents that may accentuate the body's
natural ability to promote revascularization and/or wound
healing.
[0024] The guidable elongated flexible ultrasound device also
includes an endoscopic visualization device 32 for visualizing an
area of interest. The device extends longitudinally through the
lumen 22 of the elongated tubular body 10 and comprises an outer
sheath having at least one image transmitting optical fiber bundle
and possibly one or more additional fiber bundles extending
longitudinally throughout. The image transmitting optical fiber
bundle in encircled by a plurality of light transmitting optical
fiber bundles that also extend longitudinally along the outer
sheath. At its proximal end, the visualization device is connected
to at least one machine that may be suitable for allowing a
physician skilled in the art to visualize an area of interest or
the present location within the vasculature of the guidable
elongated flexible ultrasound device.
[0025] FIG. 2 illustrates a schematic of a human heart 40 showing
percutaneous revascularization of the myocardium 30 using the
invention drawn in FIG. 1. The distal head 16 of the elongated
tubular body 10 is inserted percutaneously into a major blood
vessel (such as the femoral arterial or another peripheral vessel),
into and through the aorta 44 to the heart 40, and into a ventricle
46 to an area in need of increased blood circulation 48. Ultrasonic
energy from the distal head 16 is used to massage an area of
interest so as to generate a thrombus. Angiogenic materials or
contrasting agents can then be injected through the needle 20
mounted adjacent to the elongated tubular body 10 through the
endocardium 28 and into or near the thrombus.
[0026] FIG. 3 illustrates an embodiment of a guidable elongated
flexible ultrasound device similar to that drawn in FIG. 1. The
guidable elongated flexible ultrasound device includes an elongated
tubular body 110 with at least one lumen 112, with a proximal end
closest to the outside of the body and a distal end closest to an
area of interest within a patient's heart. The distal head 116 of
the elongated tubular body includes an ultrasonic catheter device
that can be connected to a signal generator by an ultrasound
transmission lead 18. Ultrasonic energy can pass through the distal
head 116 via the ultrasound transmission lead to an area of
interest and can be used to massage the myocardium 30. A sufficient
amount of massaging can lead to the formation of at least one
thrombus 26 wherein blot clotting and wound healing can take place
and lead to myocardial revascularization.
[0027] The guidable elongated flexible ultrasound device also
includes an endoscopic visualization device 32 for visualizing said
area of interest. The device extends longitudinally through the
lumen 122 of the elongated tubular body 110 and comprises an outer
sheath having at least one image transmitting optical fiber bundle
and possibly one or more additional fiber bundles extending
longitudinally throughout. At its proximal end, the visualization
device can be connected to at least one machine suitable for
allowing a physician skilled in the art to visualize an area of
interest or the present location within the vasculature of the
guidable elongated flexible ultrasound device.
[0028] The guidable elongated flexible ultrasound device can reach
an area of interest by first inserting a guidewire 19 into the
patient's vasculature and passing the elongated tubular body 110
over said guidewire 19. In the preferred embodiment, the guidewire
19 can pass through a lumen within the elongated tubular body
ranging from the elongated tubular body's far proximal end through
the distal head and then through a lumen 121 within said distal
head. Then, the elongated tubular body 110 can be passed over said
guidewire 19 through a lumen therein to an area of interest.
[0029] In the current embodiment, a needle 120 for injecting
materials 124 into or near a thrombus 26 is mounted within the
lumen 112 of the elongated tubular body 110 and passes through the
distal head 116. The distal head 116 still retains its ability to
transmit ultrasonic energy so as to generate at least one thrombus
26 within the myocardium 30. The lumen 122 of the needle 120 is of
sufficient diameter to allow passage of angiogenic materials or
contrasting agent. Angiogenic materials may include
pharmaceutically active compounds, nucleic acids (including
polynucleotide sequences), peptides (including polypeptides and
proteins), oligonucleotides, ribozymes, anti-sense genes, DNA
compacting agents, and gene/vector systems (i.e., anything that
allows for the uptake and expression of nucleic acids) including
but not limited to those listed previously. Contrasting agents may
include saline, radioactive compounds, and anti-thrombin compounds
including but not limited to those listed previously.
[0030] Numerous advantages of the invention covered by this
document have been set forth in the foregoing description. It will
be understood, however, that this disclosure is, in many respects,
only illustrative. Changes may be made in details, particularly in
matters of shape, size, and arrangement of parts without exceeding
the scope of the invention. The invention's scope is, of course,
defined in the language in which the appended claims are
expressed.
* * * * *